ArticleSurgical endoscopy2026
Biliopancreatic diversion with duodenal switch is safe regardless of age in appropriately selected patients: an MBSAQIP analysis.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe rates of severe obesity, the proportion of the population aged 65 and older, and the utilization of biliopancreatic diversion with duodenal switch (BPD-DS) are increasing. In this context, we seek to define the safety profile of BPD-DS as patients age.
methodsWe queried the MBSAQIP database from 2020 to 2024 to identify individuals undergoing primary BPD-DS. Patients were divided into three cohorts by age (< 50 years, 50-64 years, ≥ 65 years). Baseline demographics and 30-day outcomes were compared using Fisher exact and Wilcoxon rank sum tests where appropriate. A 1:1 propensity match was created to compare the younger two cohorts. These cohorts were compared to the oldest with 1:4 propensity matches. Multivariable logistic regression modeling was used to assess predictors of complications.
results10,305 patients were identified. 7470 (72.5%) were < 50, 2488 (24.1%) were 50-64, and 347 (3.1%) were ≥ 65 years. Complication rates were higher in the older cohorts (6.9% vs 9.4% vs 10.4% (p < 0.001)). Rates of anastomotic leak, organ space infection, reoperation, and readmission all increased across age groups (all p < 0.028). After propensity matching, there were no differences in complication rates between patients ≥ 65 and the younger cohorts. On direct comparison of the younger cohorts, patients aged 50-64 experienced higher rates of reoperation (2.6% vs 1.6%, p = 0.025), readmission (5.8% vs 4.2%, p = 0.015), minor complication (6.7% vs 5.1%, p = 0.030), major complication (5.5% vs 3.2%, p < 0.001), and any complication (9.0% vs 6.9%, p = 0.008).
conclusionThe risk for postoperative complications following BPD-DS increases with age. When controlling for baseline associated conditions, patients 65 and older have outcomes equivalent to younger adults. In appropriately selected patients, BPD-DS is safe regardless of patient age.
Indexed as
Identifiers
42277423What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.